Evaro

Established in 2017 and based in Norwich, UK, Total Access Health Ltd. , dba Evaro, operates as a healthcare technology company that offers digital health solutions and healthcare accessibility. Thuria Wenbar (CEO) and Oskar Wendowski (COO) are the co-founders of the company. In January 2026, Evaro raised USD 25 million in series A funding led by Albion Capital, with participation from British Business Bank, Exceptional Ventures, Guinness Ventures, Simplyhealth Ventures and Cornerstone VC.

The company provides a digital health platform, Evaro, that empowers businesses to expand their service offerings without disruptions. The firm’s platform allows partners to tap into Evaro's fully licensed and regulated platform, gaining access to a range of benefits including regulatory compliance, instant onboarding, prescribing and fulfilment services, patient aftercare, and marketing support. Evaro's handles everything from technology integration to medication fulfilment and ongoing patient support. The company's platform's plug-and-play solution saves time and resources, allowing partners to focus on core business goals.

Evaro generates revenue through a B2B pharmaceutical infrastructure-as-a-service model, enabling consumer brands to integrate prescription medication services seamlessly into their offerings. The company will use the January 2026 funding to scale its digital pharmacy infrastructure and expand regulated online care services with partners. The company will use this January 2026 funding to scale its digital pharmacy infrastructure and expand regulated online care services with partners.